Serif Biomedicines has emerged from stealth mode to continue developing “modified DNA,” a new class of therapeutics designed ...
Confined to the house with chronic illness, Louise Kenward discovered a community of artists continuing to connect with the natural worlds from their beds and homes. Here, she explores the rich and ...
The FDA approved lunsotogene parvec-cwha as the first gene therapy for genetic hearing loss caused by biallelic OTOF variants ...